SCHEMBL5830003

SCHEMBL5830003

CC1(O)Oc2ccccc2C(=O)C1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.40
CYP19A1 P11511 8/20 0.39
RET P07949 1/20 0.39
KDR P35968 1/20 0.39
CYP3A4 P08684 1/20 0.39
ALOX15 P16050 1/20 0.39
ALDH1A1 P00352 2/20 0.36
ATM Q13315 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
TSHR P16473 1/20 0.35
ALOX12 P18054 1/20 0.35
MAPK1 P28482 1/20 0.35
CASP1 P29466 1/20 0.35
CA7 P43166 1/20 0.35
RECQL P46063 1/20 0.35
BACE1 P56817 1/20 0.35
CA9 Q16790 1/20 0.35
EHMT2 Q96KQ7 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28320415 0.84 RET (0.41) IDO1CYP19A1RETKDRCYP3A4
SCHEMBL17237773 0.77 RAD52 (0.42) CYP19A1RETKDRCYP3A4ALOX15
SCHEMBL3289417 0.77 CYP3A4 (0.42) CYP19A1RETKDRCYP3A4ALOX15
SCHEMBL2118993 0.73 GNG2 (0.37) RETKDRCYP3A4ALOX15ALDH1A1
SCHEMBL3197529 0.72 CYP19A1 (0.46) CYP19A1CYP3A4ALOX15ALDH1A1TSHR
SCHEMBL28140395 0.72 CYP3A4 (0.47) IDO1CYP19A1RETKDRCYP3A4
SCHEMBL7762100 0.71 IDO1 (0.38) IDO1CYP19A1CYP3A4ALOX15ALDH1A1
SCHEMBL30022103 0.71 IDO1 (0.38) IDO1CYP19A1CYP3A4ALOX15ALDH1A1
SCHEMBL6017369 0.70 IDO1 (0.41) IDO1CYP19A1CYP3A4ALOX15ALDH1A1
SCHEMBL28459231 0.69 SMN1; SMN2 (0.46) CYP3A4ALOX15ALDH1A1TSHRRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109293493-A With the inhibition active novel benzhydryl class compound of mycobacterium tuberculosis 清华大学 2019-02-01 CN disclosed
US-20160143878-A1 ANTIBACTERIAL AGENT JUNTENDO EDUCATIONAL FOUNDATION (JP) 2016-05-26 US disclosed
US-20150322033-A1 ANTIBACTERIAL AGENT JUNTENDO EDUCATIONAL FOUNDATION (JP) 2015-11-12 US disclosed
EP-1732913-A1 CHROMONE COMPLEXES MERCK PATENT GmbH (DE) 2006-12-20 EP disclosed
WO-2005097772-A1 CHROMONE COMPLEXES MERCK PATENT GMBH (DE) 2005-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160143878-A1 ANTIBACTERIAL AGENT MRPL21, Q6ZSR9, NQO2 IDO1 2825/4885CYP19A1 1340/4885RET 3654/4885
US-20150322033-A1 ANTIBACTERIAL AGENT Q6ZSR9, MRPL21, NQO2 IDO1 2786/4885CYP19A1 1498/4885RET 3790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.